Phospholipid-functionalized mesoporous silica nanocarriers forselective photodynamic therapy of cancer

Biomaterials

Volumn 34, Issue 30, 2013, Pages 7462-7470

  Teng, I Ting ^a,b   Chang, Ya Ju ^b   Wang, Li Sheng ^b   Lu, Hsin Yi ^b   Wu, Li Chen ^c   Yang, Chia Min ^a   Chiu, Chih Chung ^a   Yang, Chih Hsueh ^d   Hsu, Shih Lan ^d   Ho, Ja an Annie ^a,b  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL CHI NAN UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Active targeting; Mesoporous silica nanoparticle; Phospholipid capping; Photocytotoxicity; Photodynamic cancer therapy

Indexed keywords

ACTIVE TARGETING; CANCER THERAPY; MESOPOROUS SILICA; MESOPOROUS SILICA NANOPARTICLES; MICROSCOPIC ANALYSIS; PHOTOCYTOTOXICITY; PHOTODYNAMIC THERAPY (PDT); PROTOPORPHYRINS;

DRUG DELIVERY; ONCOLOGY; PHOTODYNAMIC THERAPY;

PHOSPHOLIPIDS;

CASPASE 3; CASPASE 8; CYCLIN D; CYCLIN D1; CYTOCHROME C; NANOCARRIER; PHOSPHOLIPID; PROTOPORPHYRIN; RETINOBLASTOMA PROTEIN; SILICA NANOCARRIER; SILICON DIOXIDE; SINGLET OXYGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER THERAPY; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DAMAGE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DERIVATIZATION; ENCAPSULATION; HELA CELL; HISTOGRAM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; IRRADIATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOLYSIS; PHOTOTOXICITY; PRIORITY JOURNAL; TUMOR VOLUME; ULTRAVIOLET IRRADIATION;

ACTIVE TARGETING; MESOPOROUS SILICA NANOPARTICLE; PHOSPHOLIPID CAPPING; PHOTOCYTOTOXICITY; PHOTODYNAMIC CANCER THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; DRUG CARRIERS; ENDOCYTOSIS; FLUORESCENCE; FOLIC ACID; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SPACE; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; NANOPARTICLES; NEOPLASMS; PHOSPHOLIPIDS; PHOTOCHEMOTHERAPY; POROSITY; PROTOPORPHYRINS; SILICON DIOXIDE;

MUS MUSCULUS;

EID: 84880514407     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.06.001     Document Type: Article

References (46)

1. Dolmans D.E., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nat Rev Cancer 2003, 3:380-387.
2. Castano A.P., Mroz P., Hamblin M.R. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 2006, 6:535-545.
3. Koo H., Lee H., Lee S., Min K.H., Kim M.S., Lee D.S., et al. Invivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles. Chem Commun 2010, 46:5668-5670.
4. Peng C.L., Yang L.Y., Luo T.Y., Lai P.S., Yang S.J., Lin W.J., et al. Development of pH sensitive 2-(diisopropylamino)ethyl methacrylate based nanoparticles for photodynamic therapy. Nanotechnology 2010, 21:155103.
5. Shieh Y.A., Yang S.J., Wei M.F., Shieh M.J. Aptamer-based tumor-targeted drug delivery for photodynamic therapy. ACS Nano 2010, 4:1433-1442.
6. Tijerina M., Kopeckova P., Kopecek J. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates. Photochem Photobiol 2003, 77:645-652.
7. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4:145-160.
8. Dragicevic-Curic N., Fahr A. Liposomes in topical photodynamic therapy. Expert Opin Drug Deliv 2012, 9:1015-1032.
9. van Nostrum C.F. Polymeric micelles to deliver photosensitizers for photodynamic therapy. Adv Drug Deliv Rev 2004, 56:9-16.
10. Battah S., Balaratnam S., Casas A., O'Neill S., Edwards C., Batlle A., et al. Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates. Mol Cancer Ther 2007, 6:876-885.
11. Nishiyama N., Morimoto Y., Jang W.D., Kataoka K. Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy. Adv Drug Deliv Rev 2009, 61:327-338.
12. Bechet D., Couleaud P., Frochot C., Viriot M.L., Guillemin F., Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol 2008, 26:612-621.
13. Shiah J.G., Sun Y., Kopeckova P., Peterson C.M., Straight R.C., Kopecek J. Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates. JControl Release 2001, 74:249-253.
14. Zhang J.X., Hansen C.B., Allen T.M., Boey A., Boch R. Lipid-derivatized poly(ethylene glycol) micellar formulations of benzoporphyrin derivatives. JControl Release 2003, 86:323-338.
15. Cheng S.-H., Lee C.-H., Chen M.-C., Souris J.S., Tseng F.-G., Yang C.-S., et al. Tri-functionalization of mesoporous silica nanoparticles for comprehensive cancer theranostics-the trio of imaging, targeting and therapy. JMaster Chem 2010, 20:6149.
16. Gary-Bobo M., Brevet D., Benkirane-Jessel N., Raehm L., Maillard P., Garcia M., et al. Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells. Photodiagnosis Photodyn Ther 2012, 9:256-260.
17. Gary-Bobo M., Hocine O., Brevet D., Maynadier M., Raehm L., Richeter S., et al. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. Int J Pharm 2012, 423:509-515.
18. Gary-Bobo M., Mir Y., Rouxel C., Brevet D., Basile I., Maynadier M., et al. Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors. Angew Chem Int Ed Engl 2011, 50:11425-11429.
19. Brevet D., Gary-Bobo M., Raehm L., Richeter S., Hocine O., Amro K., et al. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem Commun 2009, 1475-1477.
20. Tu J., Wang T., Shi W., Wu G., Tian X., Wang Y., et al. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape. Biomaterials 2012, 33:7903-7914.
21. Wang L.S., Wu L.C., Lu S.Y., Chang L.L., Teng I.T., Yang C.M., et al. Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding. ACS Nano 2010, 4:4371-4379.
22. Liu J., Jiang X., Ashley C., Brinker C.J. Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery. JAm Chem Soc 2009, 131:7567-7569.
23. Cho K., Wang X., Nie S., Chen Z.G., Shin D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008, 14:1310-1316.
24. Adiseshaiah P.P., Hall J.B., McNeil S.E. Nanomaterial standards for efficacy and toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010, 2:99-112.
25. Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem 2010, 21:797-802.
26. Davis M.E., Chen Z.G., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008, 7:771-782.
27. Venturoli D., Rippe B. Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am J Physiol Renal Physiol 2005, 288:F605-F613.
28. Yuan F. Transvascular drug delivery in solid tumors. Semin Radiat Oncol 1998, 8:164-175.
29. Mosinger J., Mosinger B. Photodynamic sensitizers assay: rapid and sensitive iodometric measurement. Experientia 1995, 51:106-109.
30. Cosserat-Gerardin I., Bezdetnaya L., Notter D., Vigneron C., Guillemin F. Biosynthesis and photodynamic efficacy of protoporphyrin IX (PpIX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells. JPhotochem Photobiol B 2000, 59:72-79.
31. Wang S., Gao R., Zhou F., Selke M. Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy. JMaster Chem 2004, 14:487.
32. Gorman A.A., Rodgers M.A. Current perspectives of singlet oxygen detection in biological environments. JPhotochem Photobiol B 1992, 14:159-176.
33. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine 1999, Oxford University Press, Oxford, UK, Harwood Academic. 3rd ed.
34. Thomas A.H., Suárez G., Cabrerizo F.M., Martino R., Capparelli A.L. Study of the photolysis of folic acid and 6-formylpterin in acid aqueous solutions. JPhotochem Photobiol A 2000, 135:147-154.
35. Thomas A., Einschlag F.G., Féliz M.R., Capparelli A.L. First steps in the photochemistry of folate in alkaline medium. JPhotochem Photobiol A 1998, 116:187-190.
36. Suárez G., Cabrerizo F.M., Lorente C., Thomas A.H., Capparelli A.L. Study of the photolysis of 6-carboxypterin in acid and alkaline aqueous solutions. JPhotochem Photobiol A 2000, 132:53-57.
37. Lowry O.H., Bessey O.A., Crawford E.J. Photolytic and enzymatic transformations of pteroylglutamic acid. JBiol Chem 1949, 180:389-398.
38. Cronin D., Mark T. The role of hydrophobicity in toxicity prediction. Curr Comput Aided Drug Des 2006, 2:405-413.
39. Zeisser-Labouebe M., Mattiuzzo M., Lange N., Gurny R., Delie F. Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer. JDrug Target 2009, 17:619-626.
40. Barolet D., Boucher A. Radiant near infrared light emitting diode exposure as skin preparation to enhance photodynamic therapy inflammatory type acne treatment outcome. Lasers Surg Med 2010, 42:171-178.
41. Celli J.P., Spring B.Q., Rizvi I., Evans C.L., Samkoe K.S., Verma S., et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 2010, 110:2795-2838.
42. Naderi S., Wang J.Y., Chen T.T., Gutzkow K.B., Blomhoff H.K. cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA. Mol Biol Cell 2005, 16:1527-1542.
43. Wang J.Y., Knudsen E.S., Welch P.J. The retinoblastoma tumor suppressor protein. Adv Cancer Res 1994, 64:25-85.
44. Harbour J.W., Dean D.C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 2000, 14:2393-2409.
45. Georgieva J., Sinha P., Schadendorf D. Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions. JClin Pathol 2001, 54:229-235.
46. Vermeulen K., Van Bockstaele D.R., Berneman Z.N. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003, 36:131-149.